Waters upgraded by Jefferies with a new price target
$WAT
Biotechnology: Laboratory Analytical Instruments
Industrials
Jefferies upgraded Waters from Hold to Buy and set a new price target of $415.00 from $355.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/31/2025 | $460.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 3/26/2025 | $396.00 → $407.00 | Neutral → Outperform | Robert W. Baird |
| 2/13/2025 | $450.00 | Sector Perform → Sector Outperform | Scotiabank |
| 2/10/2025 | $360.00 → $415.00 | Underweight → Equal Weight | Barclays |
| 1/10/2025 | $430.00 | Mkt Perform → Outperform | Bernstein |
| 12/23/2024 | Sector Perform | Scotiabank | |
| 10/8/2024 | $355.00 → $415.00 | Hold → Buy | Jefferies |
| 8/28/2024 | $380.00 | Overweight | Wells Fargo |
4 - WATERS CORP /DE/ (0001000697) (Issuer)
KeyBanc Capital Markets upgraded Waters from Sector Weight to Overweight and set a new price target of $460.00
Robert W. Baird upgraded Waters from Neutral to Outperform and set a new price target of $407.00 from $396.00 previously
Scotiabank upgraded Waters from Sector Perform to Sector Outperform and set a new price target of $450.00